Search

Your search keyword '"Galdiz, Juan Bautista"' showing total 10 results
Start Over Author "Galdiz, Juan Bautista"
10 results on '"Galdiz, Juan Bautista"'

3. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD

Author

Casanova, Ciro, Marin, Jose M., Martinez-Gonzalez, Cristina, de Lucas-Ramos, Pilar, Mir-Viladrich, Isabel, Cosio, Borja, Peces-Barba, German, Solanes-García, Ingrid, Agüero, Ramón, Feu-Collado, Nuria, Calle-Rubio, Miryam, Alfageme, Inmaculada, de Diego-Damia, Alfredo, Irigaray, Rosa, Marín, Margarita, Balcells, Eva, Llunell, Antonia, Galdiz, Juan Bautista, Golpe, Rafael, Lacarcel, Celia, Cabrera, Carlos, Marin, Alicia, Soriano, Joan B., Lopez-Campos, Jose Luis, Soler-Cataluña, Juan José, and de-Torres, Juan P.

Published
2015
Full Text
View/download PDF

9. Near-fatal asthma related to menstruation

Author

Martinez-Moragón, Eva, Plaza, Vicente, Serrano, José, Picado, Cesar, Galdiz, Juan Bautista, López-Viña, Antolín, and Sanchis, Joaquín

Published
2004

10. New GOLD classification: longitudinal data on group assignment.

Author

Casanova, Ciro, Marin, Jose M., Martinez-Gonzalez, Cristina, de Lucas-Ramos, Pilar, Mir-Viladrich, Isabel, Cosio, Borja, Peces-Barba, German, Calle-Rubio, Miryam, Solanes-García, Ingrid, Agüero, Ramón, de Diego-Damia, Alfredo, Feu-Collado, Nuria, Alfageme, Inmaculada, Irigaray, Rosa, Balcells, Eva, Llunell, Antonia, Galdiz, Juan Bautista, Marín, Margarita, Soler-Cataluña, Juan José, and Lopez-Campos, Jose Luis

Subjects
OBSTRUCTIVE lung diseases, SPIROMETRY, DISEASE progression, LONGITUDINAL method, DYSPNEA
Abstract

Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD). Objective: To determine the COPD patient distribution of the new GOLD proposal and evaluate how this classification changes over one year compared with the previous GOLD staging based on spirometry only. Methods: We analyzed data from the CHAIN study, a multicenter observational Spanish cohort of COPD patients who are monitored annually. Categories were defined according to the proposed GOLD: FEV1%, mMRC dyspnea, COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and exacerbations-hospitalizations. One-year follow-up information was available for all variables except CCQ data. Results: At baseline, 828 stable COPD patients were evaluated. On the basis of mMRC dyspnea versus CAT, the patients were distributed as follows: 38.2% vs. 27.2% in group A, 17.6% vs. 28.3% in group B, 15.8% vs. 12.9% in group C, and 28.4% vs. 31.6% in group D. Information was available for 526 patients at one year: 64.2% of patients remained in the same group but groups C and D show different degrees of variability. The annual progression by group was mainly associated with one-year changes in CAT scores (RR, 1.138; 95%CI: 1.074-1.206) and BODE index values (RR, 2.012; 95%CI: 1.487-2.722). Conclusions: In the new GOLD grading classification, the type of tool used to determine the level of symptoms can substantially alter the group assignment. A change in category after one year was associated with longitudinal changes in the CAT and BODE index. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results